Q2035396 (Q2035396): Difference between revisions
Jump to navigation
Jump to search
(Created a new Item) |
(Changed an Item) |
||
Property / Italian Kohesio ID | |||
Property / Italian Kohesio ID: 5la16018bp000000062 / rank | |||
Normal rank |
Revision as of 01:53, 12 March 2020
Project in Italy financed by DG Regio
Language | Label | Description | Also known as |
---|---|---|---|
English | No label defined |
Project in Italy financed by DG Regio |
Statements
5,714.0 Euro
0 references
11,428.0 Euro
0 references
50.0 percent
0 references
15 November 2016
0 references
7 December 2018
0 references
3 December 2018
0 references
TAKIS SRL
0 references
L'AZIENDA DI BIOTECNOLOGIE TAKIS PRODUCE IN MODO INNOVATIVO ED EFFICACE ANTICORPI MONOCLONALI PER CONTO PROPRIO E PER CONTO TERZI. SEBBENE MOLTO COMPETITIVA NEI PROTOCOLLI DI VACCINAZIONE, IL PROCESSO ATTUALE MANCA DI UN SISTEMA ROBOTIZZATO PER L (Italian)
0 references
Identifiers
F83G17000640007
0 references